Screener

S&M expenses

Name: BioMarin Pharmaceuticals S&M expenses by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BioMarin Pharmaceuticals·Business Segments·1 segment·Rolls up to Sales & Marketing

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	$102.53M	$122.1M	$131.33M	$174.2M	$124.93M	$142.19M
Total	—	—	—	—	—	—

Business SegmentsView metric